Tower News

Tower Hematology Oncology Medical Group is proud to be affiliated with Cedars-Sinai, a national leader in providing high-quality, patient-centered healthcare encompassing primary care as well as specialized medicine and conducting research that leads to life-saving discoveries and innovations. Learn more…


Latest Cancer News

FDA Approves Nivolumab and Ipilimumab Combination for Advanced Kidney Cancer (02-18-2019)
The Food and Drug Administration (FDA) approved the immunotherapy drugs Opdivo and Yervoy in combination as an initial, or first-line, treatment for patients with advanced kidney cancer whose disease has... Continue Reading

Keytruda Plus Inlyta Improves Survival Compared ot Sutent for Treatment of Advanced Kidney Cancer (02-18-2019)
Results from the randomized, phase III KEYNOTE-426 clinical trial show that first-line therapy with a combination of the PD-1 targeted immunotherapy Keytruda (pembrolizumab) and the VEGF-targeted tyrosine... Continue Reading

More Cancer News

Locations

Tower Hematology Oncology Medical Group
9090 Wilshire Boulevard
Suite 200
Beverly Hills, CA 90211
Phone: (310) 888-8680
Click here for map